Results RLX(1 000 nmol/L), in combination with Ab25-35 (30 mmol/L), increased the cell viability (P
目的:研究中药单体柚皮苷(NG)对体外培养的大鼠骨髓间充质干细胞(MSCs)向成骨细胞分化过程中MAPK信号通路的影响。方法:观察在正常、加入p38、ERK和JNK通路抑制剂SB203580、PD98059、SP600125及3种抑制剂全部加入的情况下,各组碱性磷酸酶(ALP)、骨钙素(BGP)、I型胶原(Col Kinase 抑制剂 Library high throughput I)等骨向分化指标的差异。用Western blotting技术检测各组p38、ERK1/2和JNK蛋白的磷酸化水平,用荧光定量PCR技术检测细胞因子转化生长因子β1(TGF-β1)、骨形成蛋白2(BMP-2)和核心结合因子α1(Cbfα1)mRNA的表达。结果:(1)10-7mol/L为本实验中NG的最佳促骨向分化浓度。(2)NG最佳浓度组的ALP和BGP含量比其它各组都高(P0.05);与NG组相比,加入不同抑制剂组的ALP、BGP和ColⅠ表达量出现不同程度的降低。(3)与空白组相比,NG组JNK蛋白的磷酸化水平升高(P<0.05),p38蛋白的磷酸化水平降低(P0.05)。与NG组相比,加入不同抑制剂组的p38、ERK1/2和JNK蛋白的磷酸化水平有升高也有降低。(4)NG组上调BMP-2的表达(P<0.05),下调Cbfα1的表达(P0.05)。与NG组相比,加入不同抑制剂组的TGF-β1、BMP-2和Cbfα1

mRNA表达量出现不同程度的降低。结论:NG主要通过激活MAPK信号通路中ERK通路、JNK通路以及上调BMP-2的表达,促进MSCs的骨向分化。NG上调BMP-2的表达受MAPK通路中p38通路的影响较大。
目的研究水通道蛋白9(AQP9)mRNA表达水平、水通道蛋白9及p38蛋白表达及其磷酸化水平对肝癌细胞HepG2和肝正常细胞L-02砷摄入的影响,探讨水通道蛋白9磷酸化的调控机制。方法采用电感藕合等离子体质谱法(ICP-MS)测定细胞内砷含量。采用实时定量PCR、免疫印迹法和免疫共沉淀技术分别检测不同处理后两细胞株中水通道蛋白9 selleck mRNA、水通道蛋白9和p38蛋白表达水平及其磷酸化水平。采用SPSS统计软件分析实验数据。结果 HepG2细胞内砷含量及摄入速度高于L-02细胞。HepG2细胞的水通道蛋白9 mRNA表达水平在6 h内随NaAsO2处理时间延长而显著增加(P<0.05)。免疫沉淀实验结果显示,HepG2细胞中水通道蛋白9蛋白磷酸化水平随NaAsO2处理时间和浓度的增加而增加,而L-02细胞在各时间和浓度处理点水通道蛋白9蛋白磷酸化水平与对照相比明显增加,但处理间无明显差异;p38的磷酸化水平在两种细胞中均随砷处理时间延长而增加;SB203580抑制p38活性后能完全取消L-02细胞水通道蛋白9蛋白的磷酸化,而对HepG2细胞水通道蛋白9蛋白磷酸化无明显影响。结论水通道蛋白9的表达及磷酸化水平可能在调节细胞砷摄入中发挥重要作用,在不同细胞中水通道蛋白9蛋白磷酸化的调控机制有所差异。
AIM:

To investigate the mechanism of interleukin (IL)-6 secretion through blocking the IL-17A/IL-17A recepto (IL-17RA) signaling pathway with a short hairpin RNA (shRNA) in hepatic stellate cells (HSCs) in vitro . METHODS: HSCs were derived from the livers of adul male Sprague-Dawley rats. IL-6 expression was evalu ated using real-time quantitative polymerase

那个 chain reaction and enzyme linked immunosorbent assay. The phosphorylation activity of p38 mitogen activated pro tein kinases (MAPK) and extracellular regulated pro tein kinases (ERK) 1/2 upon induction by IL-17A and suppression by IL-17RA shRNA were examined using Western blotting.RESULTS: IL-6 expression induced by IL-17A was significantly increased compared to control in HSCs (P < 0.01 in a dose-dependent manner). Suppression of IL17RA using lentiviral-mediated shRNA inhibited IL-6 expression induced by IL-17A compared to group with only IL-17A treatment (1.44 ± 0.17 vs 4.07 ± 0.43, P < 0.01). IL-17A induced rapid phosphorylation of p38 MAPK and ERK1/2 after 5 min exposure, and showed the strongest levels of phosphorylation of p38 MAPK and ERK1/2 at 15 min in IL-17A-treated HSCs. IL-6 mRNA expression induced by IL-17A (100 ng/mL) for 3 h exposure was inhibited by preincubation with specific inhibitors of p38 MAPK (SB-203580) and ERK1/2 (PD-98059) compared to groups without inhibitors preincubation (1.67 ± 0.24, 2.01 ± 0.10 vs 4.08 ± 0.59, P < 0.01). Moreover, lentiviral-mediated IL-17RA shRNA 1 inhibited IL-17A-induced IL-6 mRNA expression compared to random shRNA in HSCs (1.44 ± 0.17 vs 3.98 ± 0.